Animal study finds quercetin inhibits lung cancer cell migration and enhances immune response — Evidence Review
Published in Cell Death Discovery, by researchers from Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg
Researched by
— the AI search engine for science
Table of Contents
A new study from Universitätsklinikum Erlangen finds that quercetin, a natural compound in common foods, can slow lung cancer cell growth and migration in laboratory and animal models. Related studies generally support these findings, indicating quercetin and similar natural compounds may hinder cancer progression through multiple mechanisms.
- Multiple prior studies report that quercetin inhibits cancer cell migration, invasion, and metastasis across different cancer types, including lung, melanoma, colorectal, and head and neck cancers, often by targeting key signaling pathways and cytoskeletal elements 1 2 3 4 5.
- Evidence from both in vitro and in vivo research suggests quercetin’s anticancer effects may extend to immune modulation and the tumor microenvironment, aligning with the new study’s findings on immune and microbiome changes in mice 6 7 8.
- Epidemiological studies associate higher dietary quercetin intake with reduced lung cancer risk, especially among smokers, further supporting the potential relevance of the new laboratory findings to human health 11 13 15.
Study Overview and Key Findings
Lung cancer remains a leading cause of cancer mortality, and current therapies are not effective for all patients. The search for additional or complementary treatments has turned attention to bioactive plant compounds like quercetin, which is abundant in the diet and known for its anti-inflammatory and antioxidant properties. This study is notable for its multi-level approach—testing quercetin’s effects not just in isolated lung cancer cells, but also in mouse lung tissue and living animals, and for examining immune and gut microbiome responses alongside tumor behaviors.
| Property | Value |
|---|---|
| Study Year | 2026 |
| Organization | Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg |
| Journal Name | Cell Death Discovery |
| Authors | Christine Carvalho, Elvedina Nendel, Susanne Mittler, Sonja Trump, Adriana Geiger, Jonas Willar, Mircea T. Chiriac, Stefan Wirtz, Carol I. Geppert, Susetta Finotto |
| Population | Laboratory-grown lung cancer cells, mouse lung tissue, living mice |
| Methods | Animal Study |
| Outcome | Effects of quercetin on lung cancer cell processes and immune response |
| Results | Quercetin nearly stopped migration of lung cancer cells at high doses. |
Literature Review: Related Studies
To place the new findings in context, we searched the Consensus database (over 200 million papers) using the following queries:
- quercetin lung cancer cell migration
- natural compounds cancer treatment effects
- dietary quercetin dosage lung cancer prevention
The following table groups related findings into major topic areas:
| Topic | Key Findings |
|---|---|
| How does quercetin affect cancer cell migration and metastasis? | - Quercetin inhibits migration and invasion of lung, melanoma, colorectal, and head and neck cancer cells by interfering with pathways such as Snail-Akt, HGF/c-Met, and MMP activity 1 2 3 4 5. - It disrupts cytoskeletal elements, induces apoptosis and mitotic catastrophe, and downregulates EMT markers, contributing to reduced metastatic potential 2 3 5. |
| What mechanisms underlie quercetin’s anticancer effects? | - Quercetin targets multiple cellular processes, including EGFR signaling, oxidative stress, and immune pathways, supporting its multi-targeted effects observed in cell and animal studies 4 11 12 14. - It regulates apoptosis, cell cycle progression, and immune-related signaling, with evidence for effects on the tumor microenvironment and gut microbiome 6 7 8 9. |
| Can dietary quercetin reduce lung cancer risk in humans? | - Case-control and epidemiological studies suggest that higher intake of quercetin-rich foods is associated with lower lung cancer risk, particularly among smokers 11 13 15. - The preventive effects may be more pronounced for certain lung cancer subtypes, like squamous cell carcinoma, and may depend on genetic factors 13 15. |
| What is the potential of natural compounds as cancer therapy adjuvants? | - Natural compounds, including quercetin, may enhance efficacy and reduce toxicity of conventional cancer therapies, with combination strategies showing promise 7 8 10. - Clinical evidence remains limited, and further studies are needed to clarify optimal dosing, safety, and interactions with standard treatments 6 7 8 10. |
How does quercetin affect cancer cell migration and metastasis?
Numerous in vitro and in vivo studies demonstrate that quercetin suppresses cancer cell migration, invasion, and metastasis through diverse molecular mechanisms. These mechanisms include inhibition of key signaling pathways (such as Snail-Akt and HGF/c-Met), downregulation of EMT markers, and disruption of cytoskeletal integrity. The new study’s observation that quercetin nearly halted lung cancer cell migration aligns with this body of research.
- Quercetin inhibits HGF/c-Met signaling, leading to reduced melanoma cell migration and invasion 1.
- In lung cancer cells, quercetin suppresses invasion and bone metastasis by targeting Snail-Akt and ADAM9 pathways 2.
- Studies on colon and head and neck cancer report similar anti-migratory effects, mediated by modulation of EMT markers and matrix metalloproteinases 3 4.
- Disruption of microfilaments, microtubules, and vimentin by quercetin in lung cancer cells correlates with reduced migration and induction of cell death 5.
What mechanisms underlie quercetin’s anticancer effects?
Quercetin’s anticancer activity appears to be multi-faceted, involving direct effects on tumor cells and modulation of the tumor microenvironment. The compound’s capacity to influence EGFR and immune signaling, reduce oxidative stress, and alter the gut microbiome is supported by both the new study and prior literature.
- Quercetin downregulates EGFR signaling, which is critical for cancer cell growth and survival 4 11 12.
- It modulates oxidative stress and apoptosis, with dose-dependent biphasic effects (antioxidant at lower, pro-oxidant at higher concentrations) 11 12 14.
- Immunomodulatory effects, such as increased interferon signaling and alterations in gut microbiota, echo findings from studies on natural compounds in cancer therapy 6 7 8.
- These diverse mechanisms support the notion that quercetin acts at multiple points in cancer development and progression 9 14.
Can dietary quercetin reduce lung cancer risk in humans?
Epidemiological evidence suggests a protective association between dietary quercetin and lung cancer risk, especially among smokers. While causality cannot be established from these studies, the observed risk reductions reinforce laboratory findings and support further investigation in clinical settings.
- Higher intake of quercetin-rich foods (onions, apples, citrus) correlates with lower lung cancer incidence, particularly for certain histological subtypes 11 13 15.
- The risk reduction is more evident among individuals with higher exposure to tobacco smoke, and may involve modulation of carcinogen metabolism 13 15.
- The new study’s suggestion that a quercetin-rich diet could support lung cancer prevention is consistent with these observations, though randomized trials are needed 11 13.
What is the potential of natural compounds as cancer therapy adjuvants?
A growing body of research evaluates the use of natural compounds alongside conventional cancer treatments. Reviews highlight their potential to enhance efficacy, reduce resistance, and minimize toxicity, but also caution that clinical evidence is still emerging and that herb-drug interactions require careful monitoring.
- Combination therapy with natural compounds, including quercetin, may be more effective and safer than single-agent approaches in cancer prevention and treatment 7 10.
- Some studies report that plant-derived compounds can enhance the effectiveness of chemotherapy, sensitize tumors to drugs, or provide chemoprotective effects 8 10.
- Evidence for immunomodulatory and multi-targeted actions supports further research into natural compounds as adjuncts to standard cancer care 6 7 8.
- Clinical trials and mechanistic studies are needed to optimize dosing, assess safety, and identify patient populations most likely to benefit 6 7 8 10.
Future Research Questions
Despite promising laboratory and animal data, important questions remain about quercetin’s role in lung cancer treatment and prevention. Further studies are needed to establish clinical efficacy, determine optimal dosing, and clarify mechanisms of action.
| Research Question | Relevance |
|---|---|
| Does quercetin supplementation improve clinical outcomes in lung cancer patients? | Clinical trials are needed to confirm whether the promising effects seen in preclinical studies translate to improved survival, reduced metastasis, or better quality of life in human lung cancer patients 2 11 12. |
| What are the optimal dosage and formulation of quercetin for cancer therapy? | Determining safe and effective dosage forms, considering bioavailability and metabolic conversion, is critical for both efficacy and safety in clinical use 11 12 14. |
| Can quercetin-rich diets reduce lung cancer risk in prospective population studies? | While case-control studies suggest a protective effect, prospective cohort studies are required to confirm causality and understand the potential preventive impact of dietary quercetin 13 15. |
| How does quercetin interact with standard chemotherapy regimens in lung cancer? | Investigating potential synergies or adverse interactions between quercetin and conventional chemotherapies will inform its safe integration into treatment protocols 7 8 10. |
| What are the immunomodulatory mechanisms of quercetin in lung cancer models? | Understanding how quercetin impacts immune signaling, tumor microenvironment, and microbiome composition could reveal new therapeutic targets and combinatorial strategies 6 8 9. |